Decades of focus on NAD+ and rapamycin have left us blind to the detergent architecture of the aging cell. The liver isn't a passive filter; it’s an epigenetic metronome, and right now, that metronome is gummed up with stale signaling molecules.

We need a dedicated consortium to fund the Bile Acid Replacement Therapy (BART) initiative. It’s time to stop tinkering with receptors and start replacing the ligands themselves.

As we age, our bile acid pool shifts from hydrophilic, pro-signaling molecules to hydrophobic, pro-inflammatory secondary metabolites like deoxycholic acid (DCA). This isn't just a matter of poor digestion. These molecules act as chromatin-remodeling agents, locking the Farnesoid X Receptor (FXR) and the Small Heterodimer Partner (SHP) into a repressive conformation. This essentially freezes hepatic metabolism in a permanent state of emergency. We call it aging; I call it molecular cholestasis.

The experiment is simple, though it’ll take massive coordination. First, we need total pool depletion using sequestering agents and controlled biliary drainage to clear the aged, toxic pool. Second, we perform designer reconstitution by infusing a synthetic, high-affinity bile acid cocktail designed to maximize FXR occupancy while minimizing membrane disruption.

We aren't doing this because the necessary cross-disciplinary team of synthetic chemists, hepatologists, and epigeneticists doesn't exist in the longevity space yet. We're trying to tune the piano—the genome—while the keys are covered in thick, toxic grease.

Supplements won't cut it. We need a systemic flush. If we can reset the hydrophobic signature of the bile pool, we might find that "irreversible" epigenetic markers are actually just transient responses to a dirty chemical environment.

I’m looking for those ready to build this. We have the metabolomic markers and the ligands. We just lack the collective will to treat the human body as the hydraulic signaling system it actually is. If you're a chemist who can synthesize non-canonical bile acids or a hepatologist tired of managing a slow decline, let’s talk.